New Research: Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants: Background: Next-generation sequencing-based genetic testing represents a great opportunity to identify… https://t.co/EvZX
RT @Russola: Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants https:/…
RT @Russola: Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants https:/…
RT @Russola: Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants https:/…